91 Blue Ravine Rd
Tel: +1 916-985-7888
About Agilent Technologies
Premier Laboratory Partner for a Better World
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services, and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us.
Whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals, or food testing, Agilent provides laboratory solutions to meet their full spectrum of needs. We work closely with customers to help address global trends that impact human health and the environment and to anticipate future scientific needs. Our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management.
Customers trust Agilent for solutions that enable insights...for a better world.
490 articles with Agilent Technologies
InterVenn has announced a collaboration with Agilent Technologies, a leading provider of bio-analytical and scientific instrumentation.
Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency (ACT) certification. Recognition of these products by My Green Lab highlights Agilent's commitment to pursuing sustainability throughout the production and lifecycle
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The worldwide competition, held by R&D World , recognizes R&D pioneers and their revolutionary contributions to science an
Agilent Technologies Inc. announced that a quarterly dividend of 18 cents per share of common stock will be paid on Oct. 28, 2020, to all shareholders of record as of the close of business on Oct. 6, 2020.
Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be available for the investment community. The details: What: Wells Fargo 2020 Virtual Healthcare Conference When: Wednesday, Sept. 9 at 10:40 a.m. (EDT) Who: Bob McMahon, Agilent chief financial officer Wh
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit . This solution features a modular design that enables a simple and parallel approach for both RNA and DNA samples, allowing customers to streamline and consolidate their workflow without losing time optimizing different kits for different s
Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology backed by the industry’s best service and support.
Agilent Technologies Inc. (NYSE: A) today announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and RNA molecules used to create nucleic acid-based therapeutics.
Intabio Signs Co-Marketing Agreement with Agilent Technologies Inc. to Support Development of Integrated iCIEF-MS Assay
Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces a co-marketing and equipment loan agreement with Agilent Technologies Inc. to support development of integrated iCIEF-MS assays by interfacing Intabio's Blaze
Agilent Technologies Inc. announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission.
Agilent Technologies, Inc. announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million.
Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both deliver even faster detection of target compounds providing customers increased sample throughput and reduc
Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community.
Agilent Technologies Inc. reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year.
A four-year-old legal battle between Agilent Technologies and Twist Bioscience came to a conclusion Thursday. Twist agreed to pay Agilent $22.5 million to settle the lawsuit filed in 2016.
Biofidelity and Agilent complete successful molecular assay study for rapid and accurate detection of key lung cancer mutations
Biofidelity assay has potential to make high precision, cost-effective and non-invasive diagnosis more widely available, improving treatment and patient outcomes
11/29/2019The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.
High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio
Technavio has been monitoring the global high-performance liquid chromatography market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period.
Achieves industry leadership recognition in DJSI’s Life Sciences Tools and Services category for fifth consecutive year
Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis